Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The SUZ12 mRNA 3′ untranslated region (3′UTR) is a critical regulatory segment of the messenger RNA encoding the Suppressor of Zeste 12 (SUZ12) protein, which serves as an essential structural scaffold for the Polycomb Repressive Complex 2 (PRC2). This region contains multiple cis-regulatory elements and binding sites for microRNAs (miRNAs), such as miR-767-5p, miR-200b, and miR-877-5p, which post-transcriptionally control SUZ12 expression by modulating mRNA stability and translational efficiency (Source: 1.1.2, 1.3.2). In various malignancies, including glioblastoma and lung adenocarcinoma, the downregulation of these regulatory miRNAs leads to the overexpression of SUZ12, which in turn drives aberrant PRC2-mediated trimethylation of histone H3 at lysine 27 (H3K27me3) and the silencing of tumor suppressor genes (Source: 1.1.3, 1.2.1). Consequently, the SUZ12 mRNA 3′UTR has emerged as a potential therapeutic target for RNA-based modalities, such as miRNA mimics or antisense oligonucleotides (ASOs), designed to reduce SUZ12 levels and restore normal epigenetic programming (Source: 1.2.2, 1.3.4). While targeting this region offers a precise mechanism for downregulating the PRC2 complex, therapeutic development must address the risks of off-target effects and the potential for systemic toxicity, as PRC2 is vital for normal development and the maintenance of cell identity (Source: 1.1.4, 1.2.5).
RNA interference (RNAi) and translational repression by binding to complementary sequences in the 3′UTR, leading to mRNA degradation or inhibition of protein synthesis.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Suppressor of zeste 12 protein homolog mRNA 3′ untranslated region (SUZ12 mRNA 3′UTR).